Canada Pension Plan Investment Board raised its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 8.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,286 shares of the biotechnology company's stock after acquiring an additional 3,799 shares during the quarter. Canada Pension Plan Investment Board owned approximately 0.07% of Axon Enterprise worth $30,480,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the business. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $45,000. Stonebridge Financial Group LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $53,000. GPS Wealth Strategies Group LLC lifted its position in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after buying an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc lifted its position in Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after acquiring an additional 95 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
AXON has been the subject of a number of research analyst reports. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target for the company. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $626.45.
Read Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Performance
NASDAQ:AXON traded up $10.78 during mid-day trading on Friday, hitting $601.45. 222,010 shares of the stock were exchanged, compared to its average volume of 772,575. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm's 50-day simple moving average is $547.64 and its 200 day simple moving average is $569.50. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The stock has a market capitalization of $46.82 billion, a price-to-earnings ratio of 155.41, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.
Insider Activity at Axon Enterprise
In related news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.